Gut-brain-immune interactions in neonatal hypoxic-ischemic brain injury

Area of Science:

• Neuroscience
• Immunology
• Microbiology

Background:

• Neonatal hypoxia-ischemia (HI) is a leading cause of mortality and neurodevelopmental disability in infants.
• Current treatments like therapeutic hypothermia have limited efficacy for many affected infants.
• The gut microbiome and immune system are increasingly recognized as crucial in modulating brain injury and recovery.

Purpose of the Study:

• To explore the role of the gut-brain-immune axis in neonatal HI.
• To identify potential therapeutic targets within the gut microbiome for HI.
• To understand the systemic nature of HI beyond the brain.

Main Methods:

• Review of preclinical (animal models) and clinical data on gut microbiota and immune responses in neonatal HI.
• Examination of fecal microbiota transplantation studies.
• Analysis of immune alterations in HI-affected neonates and their correlation with microbial changes.

Main Results:

• Neonatal HI induces gut dysbiosis and barrier dysfunction, linked to neuroinflammation.
• Microbial perturbations are observed in infants with hypoxic-ischemic encephalopathy (HIE).
• Peripheral immune responses are dysregulated in neonates post-HI, with some lasting effects.

Conclusions:

• Viewing neonatal HI as a systemic gut-brain-immune disease offers new therapeutic and biomarker avenues.
• Future research requires longitudinal multi-omic studies and sex-stratified analyses.
• Rigorous evaluation of microbiome-targeted interventions is essential for clinical translation.